Similar articles

• [VALUE study underscores the importance of reaching goal blood pressure values for minimization of cardiovascular risks].

  [No authors listed] [No authors listed] Praxis (Bern 1994). 2004 Oct 27;93(44):1836. Praxis (Bern 1994). 2004. PMID: 15559910 German. No abstract available.
• Exforge HCT.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Jun 15;51(1314):47. Med Lett Drugs Ther. 2009. PMID: 19528888 No abstract available.
• Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.

  Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Ruilope LM, et al. Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006. Clin Ther. 2005. PMID: 15978306 Clinical Trial.
• Changing concepts in the management of hypertension: the role of effective and prompt blood pressure reduction.

  Berbari AE, Khayat A, Daouk N, Daouk M. Berbari AE, et al. J Med Liban. 2008 Oct-Dec;56(4):226-9. J Med Liban. 2008. PMID: 19115597 Review. No abstract available.
• [Recent intervention studies with antihypertensive drugs and their influence on guidelines].

  Rahn KH. Rahn KH. Med Klin (Munich). 2003 Dec 15;98(12):771-5. doi: 10.1007/s00063-003-1323-4. Med Klin (Munich). 2003. PMID: 14685679 Review. German.